SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-009481
Filing Date
2022-02-25
Accepted
2022-02-25 16:27:02
Documents
13
Period of Report
2022-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156204-8k_helixacq.htm   iXBRL 8-K 45977
2 CONVERTIBLE LOAN AGREEMENT, DATED AS OF FEBRUARY 20, 2022, BY AND AMONG CORMORAN ea156204ex10-1_helixacq.htm EX-10.1 138573
  Complete submission text file 0001213900-22-009481.txt   393832

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hlxa-20220220.xsd EX-101.SCH 3069
4 XBRL LABEL FILE hlxa-20220220_lab.xml EX-101.LAB 35156
5 XBRL PRESENTATION FILE hlxa-20220220_pre.xml EX-101.PRE 23053
7 EXTRACTED XBRL INSTANCE DOCUMENT ea156204-8k_helixacq_htm.xml XML 3915
Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116
Business Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET FL 52 BOSTON MA 02116 857 702 0370
Helix Acquisition Corp (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 22680505
SIC: 2834 Pharmaceutical Preparations